U.S., March 5 -- ClinicalTrials.gov registry received information related to the study (NCT06855745) titled 'Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.' on Feb. 27.
Brief Summary: A Phase 2b study investigating the efficacy of zabalafin in people with mild to moderate atopic dermatitis (eczema).
Study Start Date: March 10
Study Type: INTERVENTIONAL
Condition:
Atopic Dermatitis (Eczema)
Atopic Dermatitis Eczema
Atopic Dermatitis
Atopic Dermatitis (AD)
Eczema
Eczema, Atopic
Intervention:
DRUG: zabalafin
Active IP
Recruitment Status: RECRUITING
Sponsor: Alphyn Biologics
Published by HT Digital Content Services with permission from Health Daily Digest....